Researchers tested different antibiotics on mice that resulted in microbiota changes and various susceptibility to C. difficile.
They found Clostridium scindens, a microbe that is part of the gut’s natural flora,was linked to resistance to C. difficile infections. Additionally, when administering Clostridium scindens, resistance to infection was enhanced, according to the study.
Researchers suggest Clostridium scindens is a strong probiotic candidate for restoring the gut microbiome in the event of a C. difficle infection and that their findings have implications for designing antimicrobials and therapeutics for patients at risk of developing such infections.
More articles on HAIs:
Preventing SSIs: The sterile processing connection
Mission Hospital resumes elective surgeries after infection issue
How much does an inpatient C. diff infection cost?
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.